Once-Weekly Semaglutide Reduces HbA<sub>1c</sub> and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2-4 and 10.

Diabetes Ther · 2020 · PMC7193006 · PMID 32193837

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an observed trendno p-value reported

Modest changes in lipid profile were seen across the four trials, with an observed trend for reduction in levels of total and LDL cholesterol and triglycerides, and for small increases in HDL cholesterol levels, with semaglutide and comparators.

also in 504 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.